Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
beta-Lactamases | 6 | 2021 | 307 | 1.230 |
Why?
|
Growth Differentiation Factor 2 | 4 | 2020 | 27 | 0.880 |
Why?
|
MicroRNAs | 10 | 2021 | 3805 | 0.790 |
Why?
|
Aztreonam | 2 | 2021 | 10 | 0.770 |
Why?
|
Enterobacteriaceae Infections | 3 | 2020 | 190 | 0.770 |
Why?
|
Fusion Proteins, bcr-abl | 6 | 2013 | 430 | 0.750 |
Why?
|
Osteogenesis | 5 | 2020 | 1296 | 0.650 |
Why?
|
Cross Infection | 4 | 2020 | 1425 | 0.530 |
Why?
|
Bacterial Proteins | 5 | 2020 | 3861 | 0.510 |
Why?
|
Mesenchymal Stem Cells | 5 | 2020 | 1671 | 0.500 |
Why?
|
Cell Proliferation | 15 | 2019 | 10494 | 0.460 |
Why?
|
Azabicyclo Compounds | 2 | 2021 | 68 | 0.460 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 | 2011 | 687 | 0.450 |
Why?
|
Aminoglycosides | 2 | 2014 | 161 | 0.420 |
Why?
|
Recombinases | 1 | 2023 | 70 | 0.420 |
Why?
|
Hepatitis B, Chronic | 3 | 2012 | 413 | 0.410 |
Why?
|
Enterobacter cloacae | 2 | 2012 | 25 | 0.410 |
Why?
|
beta-Lactam Resistance | 2 | 2012 | 79 | 0.400 |
Why?
|
Stomach Neoplasms | 3 | 2019 | 1484 | 0.400 |
Why?
|
Auranofin | 1 | 2021 | 16 | 0.400 |
Why?
|
Carcinoma, Hepatocellular | 5 | 2017 | 2331 | 0.390 |
Why?
|
Liver Diseases | 3 | 2021 | 1307 | 0.370 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2021 | 18 | 0.370 |
Why?
|
Ceftazidime | 1 | 2021 | 57 | 0.370 |
Why?
|
Microbial Sensitivity Tests | 6 | 2024 | 1965 | 0.370 |
Why?
|
Liver Circulation | 1 | 2010 | 159 | 0.350 |
Why?
|
Aluminum Silicates | 1 | 2020 | 24 | 0.350 |
Why?
|
Receptors, Notch | 2 | 2019 | 752 | 0.350 |
Why?
|
Ligation | 2 | 2011 | 447 | 0.350 |
Why?
|
Bronchi | 2 | 2016 | 847 | 0.350 |
Why?
|
Quinolones | 2 | 2014 | 382 | 0.340 |
Why?
|
Cranial Sutures | 1 | 2020 | 99 | 0.330 |
Why?
|
Aluminum | 1 | 2020 | 152 | 0.330 |
Why?
|
Antifungal Agents | 2 | 2024 | 761 | 0.330 |
Why?
|
Monensin | 1 | 2018 | 30 | 0.320 |
Why?
|
Escherichia coli O157 | 1 | 2018 | 53 | 0.310 |
Why?
|
Liver Neoplasms | 5 | 2017 | 4362 | 0.310 |
Why?
|
Plant Extracts | 2 | 2016 | 499 | 0.310 |
Why?
|
Bacteriological Techniques | 1 | 2019 | 277 | 0.310 |
Why?
|
Lymphocyte Antigen 96 | 1 | 2017 | 21 | 0.300 |
Why?
|
Centrosome | 2 | 2009 | 211 | 0.290 |
Why?
|
Carbapenems | 3 | 2012 | 125 | 0.290 |
Why?
|
Recombinant Fusion Proteins | 4 | 2013 | 3735 | 0.280 |
Why?
|
Sulfhydryl Compounds | 1 | 2018 | 298 | 0.280 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2021 | 590 | 0.270 |
Why?
|
Anti-Bacterial Agents | 5 | 2021 | 7471 | 0.270 |
Why?
|
alpha-Fetoproteins | 1 | 2017 | 228 | 0.270 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2019 | 8635 | 0.270 |
Why?
|
Living Donors | 1 | 2010 | 651 | 0.260 |
Why?
|
K562 Cells | 7 | 2013 | 645 | 0.260 |
Why?
|
Flavonols | 1 | 2016 | 85 | 0.250 |
Why?
|
Rectum | 1 | 2020 | 902 | 0.250 |
Why?
|
Craniosynostoses | 1 | 2020 | 416 | 0.250 |
Why?
|
Hospitals, Teaching | 3 | 2024 | 1158 | 0.250 |
Why?
|
Cytoplasm | 3 | 2011 | 1503 | 0.250 |
Why?
|
Angiotensin II | 1 | 2018 | 849 | 0.250 |
Why?
|
Osteopontin | 1 | 2017 | 307 | 0.240 |
Why?
|
Candidiasis, Invasive | 1 | 2015 | 24 | 0.240 |
Why?
|
Adenoviridae | 4 | 2014 | 1098 | 0.240 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 751 | 0.230 |
Why?
|
Apoptosis | 9 | 2018 | 9526 | 0.230 |
Why?
|
Drug Resistance, Fungal | 1 | 2024 | 77 | 0.230 |
Why?
|
Hepatitis B virus | 3 | 2014 | 530 | 0.230 |
Why?
|
Toll-Like Receptor 4 | 1 | 2017 | 586 | 0.220 |
Why?
|
Meningitis, Cryptococcal | 1 | 2024 | 67 | 0.220 |
Why?
|
Candida | 1 | 2015 | 172 | 0.220 |
Why?
|
Cholestasis | 2 | 2013 | 385 | 0.220 |
Why?
|
Down-Regulation | 3 | 2019 | 2944 | 0.220 |
Why?
|
Fluconazole | 1 | 2024 | 156 | 0.220 |
Why?
|
Trans-Activators | 2 | 2014 | 2858 | 0.220 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 85 | 0.220 |
Why?
|
Growth Differentiation Factors | 2 | 2019 | 100 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Wnt1 Protein | 1 | 2014 | 123 | 0.220 |
Why?
|
Cryptococcus neoformans | 1 | 2024 | 121 | 0.220 |
Why?
|
Interleukin-8 | 1 | 2016 | 705 | 0.220 |
Why?
|
Viral Core Proteins | 1 | 2014 | 158 | 0.220 |
Why?
|
Water | 1 | 2020 | 1421 | 0.220 |
Why?
|
Cell-Penetrating Peptides | 1 | 2013 | 45 | 0.220 |
Why?
|
Methanol | 2 | 2019 | 91 | 0.220 |
Why?
|
Transfection | 7 | 2019 | 5767 | 0.210 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.210 |
Why?
|
Hydrogels | 1 | 2019 | 745 | 0.210 |
Why?
|
Oncogenes | 1 | 2019 | 1235 | 0.210 |
Why?
|
China | 6 | 2024 | 2398 | 0.210 |
Why?
|
Cell Cycle | 5 | 2018 | 2942 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 200 | 0.200 |
Why?
|
Acinetobacter Infections | 1 | 2012 | 73 | 0.200 |
Why?
|
Epithelial Cells | 2 | 2016 | 3697 | 0.200 |
Why?
|
Tissue Scaffolds | 1 | 2019 | 948 | 0.200 |
Why?
|
Cholestasis, Extrahepatic | 1 | 2011 | 52 | 0.200 |
Why?
|
HEK293 Cells | 6 | 2020 | 4294 | 0.190 |
Why?
|
Cell Differentiation | 7 | 2024 | 11674 | 0.190 |
Why?
|
Acinetobacter baumannii | 1 | 2012 | 123 | 0.190 |
Why?
|
Bile Duct Diseases | 1 | 2011 | 98 | 0.190 |
Why?
|
Coffee | 1 | 2016 | 598 | 0.190 |
Why?
|
GRB2 Adaptor Protein | 1 | 2011 | 101 | 0.190 |
Why?
|
Fibrosis | 1 | 2018 | 2076 | 0.180 |
Why?
|
Interleukin-17 | 1 | 2016 | 923 | 0.180 |
Why?
|
HSP110 Heat-Shock Proteins | 1 | 2010 | 10 | 0.180 |
Why?
|
Estrogen Receptor alpha | 1 | 2014 | 582 | 0.180 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1461 | 0.180 |
Why?
|
eIF-2 Kinase | 1 | 2011 | 147 | 0.180 |
Why?
|
Hepatitis B Antibodies | 1 | 2011 | 155 | 0.180 |
Why?
|
Escherichia coli Infections | 1 | 2014 | 524 | 0.170 |
Why?
|
Carcinoma | 1 | 2022 | 2341 | 0.170 |
Why?
|
Chemokine CXCL10 | 1 | 2011 | 311 | 0.170 |
Why?
|
src Homology Domains | 1 | 2011 | 362 | 0.170 |
Why?
|
Sterols | 1 | 2009 | 64 | 0.170 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2010 | 99 | 0.170 |
Why?
|
Period Circadian Proteins | 1 | 2009 | 97 | 0.160 |
Why?
|
Bile Ducts | 1 | 2010 | 288 | 0.160 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2011 | 656 | 0.160 |
Why?
|
Liver | 4 | 2012 | 7575 | 0.160 |
Why?
|
Computational Biology | 2 | 2022 | 3546 | 0.160 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1816 | 0.160 |
Why?
|
Hepatitis B | 1 | 2014 | 707 | 0.160 |
Why?
|
Tissue Engineering | 1 | 2019 | 1890 | 0.160 |
Why?
|
Gene Silencing | 2 | 2012 | 1503 | 0.160 |
Why?
|
Niclosamide | 1 | 2018 | 9 | 0.160 |
Why?
|
Th2 Cells | 1 | 2024 | 1079 | 0.150 |
Why?
|
Liver Transplantation | 1 | 2010 | 2399 | 0.150 |
Why?
|
Hep G2 Cells | 3 | 2014 | 379 | 0.150 |
Why?
|
beta-Galactosidase | 1 | 2009 | 575 | 0.150 |
Why?
|
Hepatitis | 1 | 2010 | 228 | 0.150 |
Why?
|
Celastrus | 1 | 2007 | 1 | 0.150 |
Why?
|
Up-Regulation | 5 | 2019 | 4138 | 0.150 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2009 | 249 | 0.150 |
Why?
|
GTPase-Activating Proteins | 1 | 2010 | 471 | 0.140 |
Why?
|
Mice, Inbred BALB C | 6 | 2017 | 6241 | 0.140 |
Why?
|
Plasmids | 1 | 2012 | 2269 | 0.140 |
Why?
|
Colorectal Neoplasms | 2 | 2017 | 6978 | 0.140 |
Why?
|
Cadherins | 1 | 2012 | 906 | 0.140 |
Why?
|
Multilocus Sequence Typing | 2 | 2020 | 102 | 0.140 |
Why?
|
Umbilical Cord | 1 | 2018 | 179 | 0.140 |
Why?
|
Genes, p53 | 1 | 2009 | 716 | 0.140 |
Why?
|
Hepacivirus | 1 | 2014 | 1342 | 0.140 |
Why?
|
Humans | 49 | 2024 | 768451 | 0.130 |
Why?
|
Interleukins | 1 | 2011 | 792 | 0.130 |
Why?
|
Surface Properties | 2 | 2020 | 1168 | 0.130 |
Why?
|
Tretinoin | 1 | 2009 | 525 | 0.130 |
Why?
|
Niacinamide | 1 | 2018 | 419 | 0.130 |
Why?
|
Adipogenesis | 1 | 2018 | 370 | 0.130 |
Why?
|
Cartilage Diseases | 1 | 2007 | 157 | 0.130 |
Why?
|
Cell Death | 1 | 2011 | 1684 | 0.130 |
Why?
|
Esophageal Neoplasms | 1 | 2016 | 1676 | 0.120 |
Why?
|
Liver Cirrhosis | 2 | 2010 | 1950 | 0.120 |
Why?
|
Pneumonia | 1 | 2016 | 2162 | 0.120 |
Why?
|
Phenylurea Compounds | 1 | 2018 | 532 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2024 | 1172 | 0.120 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2011 | 846 | 0.120 |
Why?
|
Escherichia coli | 2 | 2014 | 4220 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2009 | 2964 | 0.110 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2010 | 1322 | 0.110 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2291 | 0.110 |
Why?
|
Synovial Membrane | 1 | 2007 | 536 | 0.110 |
Why?
|
DNA Primers | 2 | 2023 | 2826 | 0.110 |
Why?
|
Mice | 14 | 2024 | 82045 | 0.110 |
Why?
|
Viral Regulatory and Accessory Proteins | 2 | 2014 | 152 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2010 | 1625 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4586 | 0.110 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9507 | 0.110 |
Why?
|
HL-60 Cells | 3 | 2011 | 364 | 0.110 |
Why?
|
Cell Line, Tumor | 6 | 2019 | 17149 | 0.100 |
Why?
|
Animals | 17 | 2024 | 169418 | 0.100 |
Why?
|
Gene Expression Regulation | 4 | 2020 | 11930 | 0.100 |
Why?
|
Blotting, Western | 4 | 2010 | 5042 | 0.100 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13708 | 0.100 |
Why?
|
DNA Methylation | 2 | 2014 | 4421 | 0.100 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 120 | 0.090 |
Why?
|
Kinetics | 2 | 2019 | 6348 | 0.090 |
Why?
|
Venous Pressure | 1 | 2010 | 55 | 0.090 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5442 | 0.090 |
Why?
|
Signal Transduction | 4 | 2018 | 23638 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2819 | 0.090 |
Why?
|
Drug Synergism | 2 | 2018 | 1765 | 0.090 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11515 | 0.090 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3637 | 0.080 |
Why?
|
Adsorption | 1 | 2020 | 198 | 0.080 |
Why?
|
Genotype | 4 | 2020 | 13047 | 0.080 |
Why?
|
Flurbiprofen | 1 | 2019 | 21 | 0.080 |
Why?
|
Sirtuin 1 | 1 | 2021 | 247 | 0.080 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2019 | 99 | 0.080 |
Why?
|
Blood Volume | 1 | 2010 | 546 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2882 | 0.080 |
Why?
|
Liver Regeneration | 1 | 2010 | 214 | 0.080 |
Why?
|
Male | 18 | 2024 | 364781 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2008 | 6527 | 0.080 |
Why?
|
Hydrolysis | 1 | 2020 | 654 | 0.080 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2021 | 238 | 0.080 |
Why?
|
Nanofibers | 1 | 2019 | 68 | 0.080 |
Why?
|
Doxycycline | 1 | 2021 | 348 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2010 | 3145 | 0.080 |
Why?
|
In Situ Nick-End Labeling | 2 | 2010 | 616 | 0.080 |
Why?
|
Hospitals, University | 1 | 2020 | 569 | 0.080 |
Why?
|
NF-kappa B | 2 | 2017 | 2491 | 0.080 |
Why?
|
Esophageal and Gastric Varices | 1 | 2010 | 212 | 0.080 |
Why?
|
HCT116 Cells | 1 | 2019 | 406 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6400 | 0.080 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2018 | 42 | 0.080 |
Why?
|
Mice, Nude | 2 | 2018 | 3635 | 0.070 |
Why?
|
Calcium Phosphates | 1 | 2019 | 173 | 0.070 |
Why?
|
Female | 20 | 2024 | 396943 | 0.070 |
Why?
|
Portal Vein | 1 | 2010 | 432 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2019 | 506 | 0.070 |
Why?
|
Diet | 1 | 2016 | 8098 | 0.070 |
Why?
|
Middle Aged | 13 | 2024 | 223418 | 0.070 |
Why?
|
Myocytes, Cardiac | 2 | 2021 | 1683 | 0.070 |
Why?
|
Chitosan | 1 | 2019 | 141 | 0.070 |
Why?
|
Bacterial Adhesion | 1 | 2018 | 305 | 0.070 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 397 | 0.070 |
Why?
|
Gene Expression | 3 | 2019 | 7605 | 0.070 |
Why?
|
Thermodynamics | 1 | 2018 | 594 | 0.070 |
Why?
|
Fibroblasts | 2 | 2018 | 4180 | 0.070 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 434 | 0.070 |
Why?
|
Blood Flow Velocity | 1 | 2010 | 1377 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2018 | 6242 | 0.070 |
Why?
|
Peptides | 1 | 2008 | 4368 | 0.070 |
Why?
|
Adenosine | 1 | 2021 | 816 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3246 | 0.070 |
Why?
|
Quinoxalines | 1 | 2018 | 297 | 0.070 |
Why?
|
Osteoclasts | 1 | 2020 | 712 | 0.070 |
Why?
|
Cell Movement | 2 | 2018 | 5223 | 0.060 |
Why?
|
Bone Regeneration | 1 | 2019 | 445 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2014 | 12813 | 0.060 |
Why?
|
Vancomycin | 1 | 2019 | 506 | 0.060 |
Why?
|
Genetic Vectors | 3 | 2018 | 3417 | 0.060 |
Why?
|
Base Sequence | 2 | 2019 | 12428 | 0.060 |
Why?
|
Thiazolidinediones | 1 | 2018 | 462 | 0.060 |
Why?
|
Angiography | 1 | 2010 | 1598 | 0.060 |
Why?
|
Cell Line | 3 | 2019 | 15609 | 0.060 |
Why?
|
Calcium-Binding Proteins | 1 | 2020 | 1085 | 0.060 |
Why?
|
Delayed-Action Preparations | 1 | 2019 | 969 | 0.060 |
Why?
|
Enzyme Activation | 2 | 2011 | 3594 | 0.060 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2014 | 142 | 0.060 |
Why?
|
Drug Combinations | 1 | 2021 | 2079 | 0.060 |
Why?
|
Spleen | 1 | 2010 | 2298 | 0.060 |
Why?
|
Osteoblasts | 1 | 2020 | 1154 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2020 | 22293 | 0.060 |
Why?
|
Protein Transport | 2 | 2011 | 1963 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 617 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2488 | 0.060 |
Why?
|
Tumor Stem Cell Assay | 1 | 2014 | 116 | 0.060 |
Why?
|
Deoxycytidine | 1 | 2018 | 888 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3816 | 0.060 |
Why?
|
Adult | 10 | 2024 | 223542 | 0.060 |
Why?
|
Lymphatic Metastasis | 1 | 2022 | 2930 | 0.060 |
Why?
|
Stress, Mechanical | 1 | 2019 | 1680 | 0.060 |
Why?
|
Mammals | 1 | 2019 | 1136 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2024 | 19041 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 682 | 0.050 |
Why?
|
Phosphorylation | 2 | 2018 | 8332 | 0.050 |
Why?
|
Risk Factors | 5 | 2021 | 74915 | 0.050 |
Why?
|
Aged | 8 | 2024 | 171520 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 3197 | 0.050 |
Why?
|
Enzyme Assays | 1 | 2013 | 104 | 0.050 |
Why?
|
Phylogeny | 1 | 2020 | 2846 | 0.050 |
Why?
|
Microscopy, Confocal | 2 | 2009 | 1977 | 0.050 |
Why?
|
Autophagy | 1 | 2021 | 1349 | 0.050 |
Why?
|
Neoplasms | 1 | 2022 | 22386 | 0.050 |
Why?
|
Intracellular Space | 1 | 2013 | 199 | 0.050 |
Why?
|
S Phase | 1 | 2014 | 425 | 0.050 |
Why?
|
G1 Phase | 1 | 2014 | 404 | 0.050 |
Why?
|
Amplified Fragment Length Polymorphism Analysis | 1 | 2012 | 10 | 0.050 |
Why?
|
Fluoroquinolones | 1 | 2014 | 309 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2019 | 3103 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 16029 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2010 | 11138 | 0.050 |
Why?
|
Pancreas | 1 | 2018 | 1703 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 1 | 2007 | 3763 | 0.050 |
Why?
|
DNA Modification Methylases | 1 | 2012 | 210 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 4298 | 0.050 |
Why?
|
Cytokines | 2 | 2024 | 7449 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59680 | 0.050 |
Why?
|
Gene Order | 1 | 2011 | 169 | 0.050 |
Why?
|
RNA, Antisense | 1 | 2011 | 136 | 0.040 |
Why?
|
Prevalence | 2 | 2020 | 15880 | 0.040 |
Why?
|
Endoscopy | 1 | 2010 | 1857 | 0.040 |
Why?
|
Biocompatible Materials | 1 | 2019 | 1703 | 0.040 |
Why?
|
Azacitidine | 1 | 2012 | 336 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3619 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2018 | 18388 | 0.040 |
Why?
|
Caspase 1 | 1 | 2021 | 227 | 0.040 |
Why?
|
Protein Binding | 2 | 2013 | 9376 | 0.040 |
Why?
|
bcl-2-Associated X Protein | 1 | 2011 | 282 | 0.040 |
Why?
|
Cyclin B1 | 1 | 2009 | 57 | 0.040 |
Why?
|
Colony-Forming Units Assay | 1 | 2010 | 352 | 0.040 |
Why?
|
Mesylates | 1 | 2009 | 37 | 0.040 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1489 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 17647 | 0.040 |
Why?
|
Oxidants | 1 | 2010 | 169 | 0.040 |
Why?
|
Cytoprotection | 1 | 2010 | 201 | 0.040 |
Why?
|
Infarction | 1 | 2021 | 249 | 0.040 |
Why?
|
DNA Fragmentation | 1 | 2009 | 240 | 0.040 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 284 | 0.040 |
Why?
|
Peptide Mapping | 1 | 2009 | 260 | 0.040 |
Why?
|
Phenotype | 2 | 2019 | 16712 | 0.040 |
Why?
|
Transposon Resolvases | 1 | 2018 | 1 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2009 | 130 | 0.040 |
Why?
|
Inpatients | 1 | 2020 | 2561 | 0.040 |
Why?
|
Protein Stability | 1 | 2010 | 584 | 0.040 |
Why?
|
Sputum | 1 | 2011 | 511 | 0.040 |
Why?
|
Flow Cytometry | 2 | 2009 | 5904 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2011 | 473 | 0.040 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2009 | 176 | 0.040 |
Why?
|
Protein Sorting Signals | 1 | 2009 | 275 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2011 | 605 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2011 | 3790 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2010 | 527 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2009 | 426 | 0.040 |
Why?
|
Bone and Bones | 1 | 2019 | 2589 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2010 | 930 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 639 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 868 | 0.040 |
Why?
|
Caspases | 1 | 2011 | 884 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3826 | 0.040 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2018 | 257 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2018 | 1755 | 0.040 |
Why?
|
Granulocytes | 1 | 2009 | 550 | 0.040 |
Why?
|
CpG Islands | 1 | 2012 | 1209 | 0.040 |
Why?
|
Immunoassay | 1 | 2011 | 746 | 0.040 |
Why?
|
Nanoparticles | 1 | 2019 | 1986 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12561 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2020 | 3805 | 0.030 |
Why?
|
Chondrogenesis | 1 | 2018 | 239 | 0.030 |
Why?
|
Prognosis | 2 | 2022 | 30028 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2010 | 742 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2010 | 1497 | 0.030 |
Why?
|
Public Health | 1 | 2019 | 2693 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2012 | 2731 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2477 | 0.030 |
Why?
|
Necrosis | 1 | 2010 | 1621 | 0.030 |
Why?
|
Tubulin | 1 | 2009 | 695 | 0.030 |
Why?
|
Cell Transplantation | 1 | 2007 | 475 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2022 | 15460 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2009 | 2298 | 0.030 |
Why?
|
Gene Frequency | 1 | 2012 | 3615 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 1409 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14728 | 0.030 |
Why?
|
Steroids | 1 | 2009 | 937 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2009 | 998 | 0.030 |
Why?
|
Cell Separation | 1 | 2009 | 1726 | 0.030 |
Why?
|
Hyperplasia | 1 | 2007 | 1154 | 0.030 |
Why?
|
Risk | 1 | 2016 | 9642 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2018 | 5342 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2018 | 1170 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 2072 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2008 | 4175 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1766 | 0.030 |
Why?
|
Kidney | 1 | 2018 | 7064 | 0.030 |
Why?
|
Mutation | 2 | 2023 | 30243 | 0.030 |
Why?
|
Hepatocytes | 1 | 2010 | 1247 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2742 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1119 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5709 | 0.020 |
Why?
|
Binding Sites | 1 | 2011 | 6030 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5709 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2011 | 2465 | 0.020 |
Why?
|
Young Adult | 3 | 2024 | 60045 | 0.020 |
Why?
|
Alleles | 1 | 2012 | 6890 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6091 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1669 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4780 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5803 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2009 | 2889 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3108 | 0.020 |
Why?
|
Adolescent | 3 | 2024 | 89168 | 0.020 |
Why?
|
Monocytes | 1 | 2009 | 2591 | 0.020 |
Why?
|
Histones | 1 | 2010 | 2595 | 0.020 |
Why?
|
Odds Ratio | 1 | 2012 | 9687 | 0.020 |
Why?
|
Proteome | 1 | 2009 | 1881 | 0.020 |
Why?
|
Smoking | 1 | 2016 | 9099 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13452 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2910 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20231 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2011 | 903 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22365 | 0.020 |
Why?
|
Lung | 1 | 2016 | 10090 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2009 | 2238 | 0.020 |
Why?
|
Infant | 1 | 2020 | 36497 | 0.020 |
Why?
|
Chromatin | 1 | 2009 | 2969 | 0.020 |
Why?
|
DNA | 1 | 2011 | 7213 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3463 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3611 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4362 | 0.020 |
Why?
|
Prospective Studies | 1 | 2020 | 54914 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3624 | 0.020 |
Why?
|
Models, Biological | 1 | 2011 | 9505 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23839 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2009 | 5808 | 0.010 |
Why?
|
Cell Division | 1 | 2011 | 4479 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 41797 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 18048 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40271 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26395 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2015 | 81834 | 0.010 |
Why?
|
Child | 1 | 2011 | 80863 | 0.010 |
Why?
|